You can now submit your antimicrobial screening request, download all forms and access your primary screening, cytotoxicity, hit confirmation and hit validation reports online on the new secure CO-ADD user portal > Click here to login or register
What adventures are your compounds embarking on once they have arrived in our Australian laboratories?
Our microbiology team takes you on a tour of our high-throughput compound preparation for antimicrobial screening facility:
BIO 2016 AMR Focus -Global Workshop for Novel Anti-Infectives.
Together with our partners IMI and the ENABLE program, we hosted a dedicated workshop at BIO attended by over 200 delegates from 22 countries to showcase novel anti-infective companies from across the globe, with an expert panel and the audience selecting the best presentations. Switzerland-based Bioversys (R&D for small molecules switching off drug resistance against antibiotics) won the expert panel vote, while US-based EpiBiome (precision microbiome engineering) won the audience vote. You can download slides from all the presenting companies and partners at the workshop here or below.
CO-ADD has been recognised for their outstanding contributions to the UQ community at the 2016 UQ Awards for Excellence ceremony, held on 9 June at The University of Queensland.
CO-ADD welcomes Jim O'Neill's latest and final report on AMR
